Skip to content

Proflavine

Drug profile

Also known as: proflavin, proflavin hemisulfate, proflavin sulfate, proflavine hemisulfate, proflavine sulfate

FDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Proflavine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including REP. Recorded indications include Antiseptic preparation.

  • Molecular targets: REP (1 listed in DrugCentral).
  • Indications: Antiseptic preparation.
  • Molecular formula: C13H11N3; molecular weight 209.25 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Antiseptic preparation

Off-label uses (1)

  • Candidiasis of skin

Contraindications (2)

  • Aphthous ulcer of mouth
  • Vaginal irritation

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Replicase polyprotein 1abREPunknownIC50 5.84

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Proflavine is on its molecule page.

Molecular formulaC13H11N3
Molecular weight209.25 g/mol
CAS number92-62-6
InChIKeyWDVSHHCDHLJJJR-UHFFFAOYSA-N
PubChem CID7099
NC1=CC2=NC3=CC(N)=CC=C3C=C2C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Proflavine used for?

DrugCentral lists the following indications for Proflavine: Antiseptic preparation.

How does Proflavine work?

Its molecular targets in DrugCentral include REP.

What is the chemical formula of Proflavine?

Proflavine has the molecular formula C13H11N3 and a molecular weight of 209.25 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets1
Indications1
FormulaC13H11N3
DrugCentral ID2277
Interactive profile